Patents by Inventor Scott Ashley

Scott Ashley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Gene therapy for treating phenylketonuria
    Patent number: 12569525
    Abstract: Compositions and regimens useful in treating phenylketonuria are provided. The compositions include recombinant adeno-associated virus (rAAV) with a transthyretin enhancer and promoter driving expression of a human phenylalanine hydroxylase.
    Type: Grant
    Filed: June 6, 2022
    Date of Patent: March 10, 2026
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: James M. Wilson, Jenny Agnes Sidrane, Scott Ashley
  • Shaped charge systems with waveshaper-embedded fuzing
    Patent number: 12173994
    Abstract: A shaped charge system controlled by an electronic safe and arm device located outside a system chamber comprises a billet of explosive fill material in the chamber, a waveshaper disposed in the explosive material, and a detonator and firing module disposed within the waveshaper.
    Type: Grant
    Filed: April 28, 2023
    Date of Patent: December 24, 2024
    Assignee: L3Harris Technologies, Inc.
    Inventors: Zac Spears, Scott Hill, Scott Ashley, Rita Kerrigan, Justin Sweitzer, David Simmons
  • GENE THERAPY FOR TREATING PHENYLKETONURIA
    Publication number: 20220313760
    Abstract: Compositions and regimens useful in treating phenylketonuria are provided. The compositions include recombinant adeno-associated virus (rAAV) with a transthyretin enhancer and promoter driving expression of a human phenylalanine hydroxylase.
    Type: Application
    Filed: June 6, 2022
    Publication date: October 6, 2022
    Inventors: James M. Wilson, Jenny Agnes Sidrane, Scott Ashley
  • Gene therapy for treating Phenylketonuria
    Patent number: 11382941
    Abstract: Compositions and regimens useful in treating phenylketonuria are provided. The compositions include recombinant adeno-associated virus (rAAV) with a transthyretin enhancer and promoter driving expression of a human phenylalanine hydroxylase.
    Type: Grant
    Filed: December 29, 2017
    Date of Patent: July 12, 2022
    Inventors: James M. Wilson, Jenny Agnes Sidrane, Scott Ashley
  • GENE THERAPY FOR TREATING PHENYLKETONURIA
    Publication number: 20190336550
    Abstract: Compositions and regimens useful in treating phenylketonuria are provided. The compositions include recombinant adeno-associated virus (rAAV) with a transthyretin enhancer and promoter driving expression of a human phenylalanine hydroxylase.
    Type: Application
    Filed: December 29, 2017
    Publication date: November 7, 2019
    Inventors: James M. Wilson, Jenny Agnes Sidrane, Scott Ashley